• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Global Lung Cancer Therapeutics Market Report 2017-2022: Key Players are Pfizer, Ventana, Roche, Genentech, Glaxosmith, Agennix & Boehringer - Research and Markets

    Global Lung Cancer Therapeutics Market Report 2017-2022: Key Players are Pfizer, Ventana, Roche, Genentech, Glaxosmith, Agennix & Boehringer - Research and Markets

  2. Karus Therapeutics Announces First Cancer Patients Dosed with KA2507, a Small Molecule HDAC6-Selective Inhibitor, in a Phase I Clinical Trial

    Karus Therapeutics Announces First Cancer Patients Dosed with KA2507, a Small Molecule HDAC6-Selective Inhibitor, in a Phase I Clinical Trial

  3. Eureka Therapeutics Announces Presentations at Upcoming Industry Conferences

    Eureka Therapeutics Announces Presentations at Upcoming Industry Conferences

  4. amcure Presents Phase I/Ib Study Design for Lead Compound AMC303 at ESMO 2017 Congress

    amcure Presents Phase I/Ib Study Design for Lead Compound AMC303 at ESMO 2017 Congress

  5. Zymeworks to Present at the European Society for Medical Oncology 2017 Congress and Hold Webcast to Review Clinical Results

    Zymeworks to Present at the European Society for Medical Oncology 2017 Congress and Hold Webcast to Review Clinical Results

  6. ImmunoGen Announces Agreements to Exchange $76.4 Million of Its 4.50% Convertible Senior Notes Due 2021 for Common Stock

    ImmunoGen Announces Agreements to Exchange $76.4 Million of Its 4.50% Convertible Senior Notes Due 2021 for Common Stock

  7. amcure Receives Additional €1.75M BMBF Research Grant

    amcure Receives Additional €1.75M BMBF Research Grant

12345

©2017 Morningstar Advisor. All right reserved.